Free provider profile
LYNNE LYONS, MD
NPI 1780644880
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2023-01-20.
2300 HAGGERTY RD SUITE 2160, WEST BLOOMFIELD, MI, 48323
248-859-2457
Single practice location
Enumerated 2006-03-24
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,993
Medicare patients
156
Part D drug cost
$1,699,916
Brand-name share
16.8%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 157 | $1,435,665 |
| Vraylar (Cariprazine Hcl) | 37 | $63,666 |
| Nuedexta (Dextromethorphan Hbr/Quinidine) | 20 | $33,420 |
| Mounjaro (Tirzepatide) | 26 | $30,306 |
| Trintellix (Vortioxetine Hydrobromide) | 18 | $17,161 |
| Olanzapine Odt (Olanzapine) | 15 | $5,765 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 103 | $5,092 |
| Alprazolam Er (Alprazolam) | 39 | $4,517 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024914 sessions · 30 patients · $852,135
2023972 sessions · 30 patients · $890,968
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.